BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29985077)

  • 1.
    Qu X; Zhai J; Hu T; Gao H; Tao L; Zhang Y; Song Y; Zhang S
    Xenobiotica; 2019 Sep; 49(9):1116-1125. PubMed ID: 29985077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extract from Dioscorea bulbifera L. rhizomes aggravate pirarubicin-induced cardiotoxicity by inhibiting the expression of P-glycoprotein and multidrug resistance-associated protein 2 in the mouse liver.
    Sun LR; Guo QS; Zhou W; Li M
    Sci Rep; 2021 Oct; 11(1):19720. PubMed ID: 34611244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taiwanese and Japanese yam (Dioscorea spp.) extracts attenuate doxorubicin-induced cardiotoxicity in mice.
    Chen CT; Wang ZH; Hsu CC; Lin HH; Chen JH
    J Food Drug Anal; 2017 Oct; 25(4):872-880. PubMed ID: 28987364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of P-glycoprotein expression by dandelion in tumor and heart tissues: Impact on the anti-tumor activity and cardiotoxicity of doxorubicin.
    Qu J; Ke F; Yang X; Wang Y; Xu H; Li Q; Bi K
    Phytomedicine; 2022 Sep; 104():154275. PubMed ID: 35760022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Protective Effects of Diosgenin against Doxorubicin-Induced Cardiotoxicity.
    Chen CT; Wang ZH; Hsu CC; Lin HH; Chen JH
    Nutrients; 2015 Jun; 7(6):4938-54. PubMed ID: 26091236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nilotinib reverses ABCB1/P-glycoprotein-mediated multidrug resistance but increases cardiotoxicity of doxorubicin in a MDR xenograft model.
    Zhou ZY; Wan LL; Yang QJ; Han YL; Li D; Lu J; Guo C
    Toxicol Lett; 2016 Sep; 259():124-132. PubMed ID: 27491883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Ntcp, Oatp2, Bsep and Mrp2 in liver injury induced by Dioscorea bulbifera L. and Diosbulbin B in mice.
    Qu XY; Tao LN; Zhang SX; Sun JM; Niu JQ; Ding YH; Song YQ
    Environ Toxicol Pharmacol; 2017 Apr; 51():16-22. PubMed ID: 28262508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in P-glycoprotein expression in mouse tissues by doxorubicin: implications for pharmacokinetics in multiple dosing regimens.
    Gustafson DL; Long ME
    Chem Biol Interact; 2001 Oct; 138(1):43-57. PubMed ID: 11640914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity.
    Ibrahim MA; Ashour OM; Ibrahim YF; El-Bitar HI; Gomaa W; Abdel-Rahim SR
    Pharmacol Res; 2009 Nov; 60(5):373-81. PubMed ID: 19467331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aidi injection reduces doxorubicin-induced cardiotoxicity by inhibiting carbonyl reductase 1 expression.
    Lu Y; Liu W; Lv T; Wang Y; Liu T; Chen Y; Jin Y; Huang J; Zheng L; Huang Y; He Y; Li Y
    Pharm Biol; 2022 Dec; 60(1):1616-1624. PubMed ID: 35980105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the pharmacokinetics and cardiotoxicity of doxorubicin in rat receiving nilotinib.
    Zhou ZY; Wan LL; Yang QJ; Han YL; Li Y; Yu Q; Guo C; Li X
    Toxicol Appl Pharmacol; 2013 Oct; 272(1):238-44. PubMed ID: 23770382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective Effects Of Trimetazidine Against Doxorubicin-Induced Cardiotoxicity And Hepatotoxicity In Mice.
    Sikandar A; Farhat K; Afzal A; Ajmal K; Laeeq M; Khokhar A
    J Ayub Med Coll Abbottabad; 2020; 32(3):304-309. PubMed ID: 32829541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of carnosine and carnosine plus vitamin E treatments on doxorubicin-induced oxidative stress and cardiac, hepatic, and renal toxicity in rats.
    Kumral A; Giriş M; Soluk-Tekkeşin M; Olgaç V; Doğru-Abbasoğlu S; Türkoğlu Ü; Uysal M
    Hum Exp Toxicol; 2016 Jun; 35(6):635-43. PubMed ID: 26224044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
    Saad SY; Najjar TA; Alashari M
    J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute doxorubicin toxicity differentially alters cytochrome P450 expression and arachidonic acid metabolism in rat kidney and liver.
    Zordoky BN; Anwar-Mohamed A; Aboutabl ME; El-Kadi AO
    Drug Metab Dispos; 2011 Aug; 39(8):1440-50. PubMed ID: 21571947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Cremophor EL on the pharmacokinetics, antitumor activity and toxicity of doxorubicin in mice.
    Badary OA; Al-Shabanah OA; Al-Gharably NM; Elmazar MM
    Anticancer Drugs; 1998 Oct; 9(9):809-15. PubMed ID: 9840728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Roles of
    Djabir YY; Arsyad MA; Sartini S; Lallo S
    Pharmacognosy Res; 2017; 9(2):168-173. PubMed ID: 28539741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo protection of dna damage associated apoptotic and necrotic cell deaths during acetaminophen-induced nephrotoxicity, amiodarone-induced lung toxicity and doxorubicin-induced cardiotoxicity by a novel IH636 grape seed proanthocyanidin extract.
    Ray SD; Patel D; Wong V; Bagchi D
    Res Commun Mol Pathol Pharmacol; 2000; 107(1-2):137-66. PubMed ID: 11334364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoceria ameliorates doxorubicin induced cardiotoxicity: Possible mitigation via reduction of oxidative stress and inflammation.
    Sangomla S; Saifi MA; Khurana A; Godugu C
    J Trace Elem Med Biol; 2018 May; 47():53-62. PubMed ID: 29544808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slow infusion rate of doxorubicin induces higher pro-inflammatory cytokine production.
    Tien CC; Peng YC; Yang FL; Subeq YM; Lee RP
    Regul Toxicol Pharmacol; 2016 Nov; 81():69-76. PubMed ID: 27494949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.